Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh (950210) Price & Analysis

Q: Is Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh overvalued?

According to Wall Street analysts Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: Which hedge fund is a major shareholder of Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh?

Currently, no hedge funds are holding shares in KR:950210

― Followers

950210 Stock Chart & Stats

₩5060.00

-₩110.00(-2.13%)

Oct 26, 2026

―

Day’s Range― - ―

52-Week Range₩4,945.00 - ₩14,120.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)26.03K

Market Cap

₩304.09B

Enterprise Value₩504.06B

Total Cash (Recent Filing)₩63.01B

Total Debt (Recent Filing)₩106.11B

Price to Earnings (P/E)―

Beta<0.01

Next Earnings

Nov 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1541.66

Shares Outstanding60,096,153

10 Day Avg. Volume34,284

30 Day Avg. Volume26,031

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)0.89

Price to Sales (P/S)14.89

P/FCF Ratio-6.21

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh News

Prestige Biopharma Deepens Oncology Focus With Biosimilars, Novel Antibodies and Platform Technologies

An announcement from Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh ( ($KR:950210) ) is now available....

1M ago

Prestige BioPharma Calls Shareholder Meeting to Refresh Board and Expand Capital-Raising Powers

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh ( ($KR:950210) ) has provided an announcement. Prestige BioPharma...

1M ago

Prestige BioPharma Insiders Lift Stake in Depositary Receipts

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh ( ($KR:950210) ) has shared an announcement. Prestige BioPharma...

2M ago

Prestige BioPharma Insiders Slightly Increase Control via Depositary Receipts

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh ( ($KR:950210) ) has issued an update. Prestige BioPharma...

2M ago

950210 FAQ

What was Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s price range in the past 12 months?

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh lowest stock price was ₩4945.00 and its highest was ₩14120.00 in the past 12 months.

What is Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s market cap?

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s market cap is ₩304.09B.

When is Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s upcoming earnings report date?

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s upcoming earnings report date is Nov 26, 2026 which is in 30 days.

How were Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s earnings last quarter?

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh released its earnings results on Sep 22, 2026. The company reported -₩730.426 earnings per share for the quarter.

Is Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh overvalued?

According to Wall Street analysts Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh pay dividends?

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh does not currently pay dividends.

What is Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s EPS estimate?

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh have?

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh has 60,096,153 shares outstanding.

What happened to Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s price movement after its last earnings report?

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh reported an EPS of -₩730.426 in its last earnings report. Following the earnings report the stock price went up 0.687%.

Which hedge fund is a major shareholder of Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh?

Currently, no hedge funds are holding shares in KR:950210

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh

Established in 2015 and based in Singapore, Prestige BioPharma Limited operates as a biopharmaceutical enterprise. The company's activities encompass the research, development, and commercialization of biosimilars and novel antibody therapeutics, primarily targeting the Asia Pacific market. A significant focus for Prestige BioPharma is the creation of antibody-based treatments for critical conditions such as solid tumors, pancreatic cancer, breast cancer, gastric cancer, and arthritis. Furthermore, the firm is also advancing the development of vaccines for the COVID-19 virus.